Aehr Test Revenue Triples to $33M as Its Backlog Rises 6.5x

Aehr Test Systems, which makes burn-in and test systems for chips including AI processors, reported record revenue of $33.0 million for its fiscal first quarter, up 200% from $11.0 million a year earlier, according to its results release of 2 November. It raised its fiscal 2027 revenue outlook to $150 million, the top of its earlier $130 million to $150 million range, and said its effective backlog had reached $109.3 million as of 1 November.

By our arithmetic, that effective backlog equals 93% of the $117.0 million in revenue Aehr still needs over the rest of the fiscal year to reach $150 million. Its backlog at the end of the quarter, $100.9 million, is 6.5 times the $15.5 million it reported at the end of the same quarter a year earlier.

Business Pill · Backlog

An evergreen Business Engineer explainer on backlog. It teaches the general idea only and does not discuss Aehr.

Where the AI Orders Come From

Chief executive Gayn Erickson tied the quarter to AI demand. “Our fiscal first quarter results demonstrate the accelerating demand for our AI semiconductor test and burn-in solutions and our ability to execute against expanding customer production requirements”, he said in the release.

In wafer-level burn-in, he said, the company’s “lead AI processor WLBI production customer continues to expand capacity”, supported by a $22 million follow-on order announced in August. A “major supplier of AI accelerators, CPUs, and network processors” that completed a benchmark evaluation last quarter has decided to buy a fully configured FOX-XP test cell for one of its outsourced assembly and test partners in Taiwan. Installation is planned for early calendar 2027, with a decision on high-volume production “anticipated within several months following installation and validation”.

In package-level burn-in, Aehr says it is “currently shipping and installing more than a dozen systems per month” of its Sonoma systems for its lead hyperscale customer’s first AI processor. That customer’s second AI processor has completed qualification on Sonoma, and Aehr has received follow-on orders for initial production sampling and an anticipated ramp in calendar 2027. According to the release, “the customer forecasts that this second processor will ultimately reach higher production volumes than its first”. Aehr does not name either customer.

What Aehr Reported

For the quarter ended 25 September 2026, GAAP gross margin was 47.5% and non-GAAP gross margin 48.5%. GAAP net income was $7.2 million, or $0.21 per diluted share, against a net loss of $2.1 million a year earlier. Non-GAAP net income was $9.4 million, or $0.28 per diluted share. Revenue rose 75% from the previous quarter’s $18.8 million.

Bookings were $46.7 million, a book-to-bill ratio of approximately 1.4, according to the release. That is below the record $60.7 million Aehr booked in its fiscal fourth quarter to May, according to its July release. The quarter is the first under a new fiscal calendar: Aehr moved its year-end to the Friday nearest 30 June, and a one-month transition period from 30 May to 26 June 2026 had revenue of $0.6 million and a net loss of $2.7 million.

The Outlook in Our Arithmetic

For fiscal 2027, ending 25 June 2027, Aehr now expects revenue of $150 million, which it says represents 200% growth over fiscal 2026, and non-GAAP net income of at least 20% of revenue. The release attributes the higher outlook to its first-quarter performance, “substantial backlog” and “increasing visibility into existing customer production programs”.

Aehr’s fiscal 2026 10-K defines backlog as product orders with confirmed purchase orders “which are scheduled for shipment within 12 months”. With $33.0 million booked as revenue in the first quarter, reaching $150 million requires $117.0 million over the remaining three quarters, an average of $39.0 million a quarter, by our arithmetic. The $109.3 million effective backlog covers 93% of that amount, and at least 20% of $150 million would be at least $30 million of non-GAAP net income. These are comparisons with the company’s own figures, not a forecast.

The quarter-end backlog is also about 3.1 times the quarter’s revenue, by our arithmetic. Across the six quarter-ends we checked, from May 2025 to September 2026, backlog went from $15.2 million to $15.5 million, $11.8 million, $38.7 million, $80.6 million and $100.9 million.

Where the Cash Went

The cash flow statement shows the cost of the ramp. Net cash used in operating activities was $3.1 million in the quarter despite net income of $7.2 million, as accounts receivable rose $10.7 million and inventories $9.0 million. Inventories reached $53.1 million at quarter-end against $41.4 million at the end of May, a rise of 28% by our arithmetic. Cash, cash equivalents and restricted cash fell to $105.1 million from $116.5 million at the end of May, and the company spent $4.5 million on shares withheld for taxes on vesting stock units.

A Concentrated Customer Base

The fiscal 2026 10-K says Aehr’s five largest customers accounted for approximately 70% of net revenue in fiscal 2026, 77% in fiscal 2025 and 93% in fiscal 2024, and that three customers accounted for approximately 26%, 14% and 11% in fiscal 2026. Package-level products, which include the Sonoma systems, were $18.5 million, or about 37% of fiscal 2026 revenue.

In the new release Erickson said Aehr now sees the potential for significant production orders “across more than a dozen customers spanning AI processors, silicon photonics, silicon carbide, gallium nitride, and other applications”, compared with “only a handful of customers” historically.

What the Risk Factors Say

Aehr had not filed its 10-Q for the quarter when we checked EDGAR on 2 November, so there is no updated risk factor section to compare. The release’s forward-looking statement names, among other risks, “the non-binding nature of customer forecasts”, “the possibility that orders are canceled, rescheduled, or delayed” and geopolitical conditions “including those affecting Taiwan and Southeast Asia”.

Connecting the Coverage

Aehr’s quarter adds a test and burn-in data point to the back end of the AI chip supply chain we have been tracking. On 30 October we laid out the AI packaging bottleneck in numbers, including ABF substrate lead times of 48 to 56 weeks. Advantest, the Japanese chip-test equipment maker, raised its operating income forecast by 14.3% on 28 October, and ASMPT booked a record HK$8.85 billion of orders with a book-to-bill ratio of 1.69. Amkor reported that computing rose to 26% of its net sales.

As we read it, the business lever in Aehr’s filing is conversion of orders into revenue: the backlog already covers most of the outlook, while the cash flow statement shows receivables and inventory absorbing the profit as shipments rise.

The Structural Read

As we read it, the outlook now depends more on shipping than on winning new orders: the $109.3 million effective backlog is close to the $117.0 million still needed, by our arithmetic.

As we read it, the ramp is being funded from the balance sheet: receivables and inventories together rose $19.7 million in the quarter by our arithmetic, more than the $7.2 million of net income.

As we read it, the customers are the open question: the release names none of them, and the 10-K shows that five customers accounted for about 70% of fiscal 2026 revenue.

Three Implications

FOR AI CHIP SUPPLIERS Aehr says a major supplier of AI accelerators, CPUs and network processors will evaluate a FOX-XP test cell in a high-volume production environment at an outsourced assembly and test partner in Taiwan, with installation planned for early calendar 2027.

FOR HYPERSCALERS DESIGNING THEIR OWN CHIPS Aehr says its lead hyperscale customer’s second AI processor has completed qualification on Sonoma, and that the customer forecasts higher production volumes for it than for its first.

FOR AEHR SHAREHOLDERS Cash, cash equivalents and restricted cash fell $11.4 million from the end of May to $105.1 million, by our arithmetic, while Aehr guided to non-GAAP net income of at least 20% of revenue for fiscal 2027.

The Business Engineer Lens

This story maps onto the Business Engineer framework The AI Supercycle.

The framework puts it this way: “Each layer is constrained by the one below it.”

It names Foundries & Packaging as the second layer from the bottom of its nine. As we read it, Aehr’s burn-in systems sit in that layer, where chips are stressed and screened before they ship. The framework was published in June 2026 and does not discuss Aehr.

Related coverage: The AI packaging bottleneck in numbers · Advantest raises profit forecast 14% · ASMPT bookings hit a record HK$8.85B

What Is Not Established

The release does not say how much of revenue, bookings or backlog comes from AI processors, and it does not name the lead hyperscale customer, the lead AI processor customer or the AI accelerator supplier. An 8-K filed on 29 October said Aehr’s board appointed Narsing Vijayrao, who was Meta Platforms’ vice president of infrastructure until August 2026, as a director; the filings do not link that appointment to any customer.

Customer forecasts are, in Aehr’s words, non-binding, and the 10-K says backlog “may not be indicative of net revenues for any succeeding period”. We did not listen to the conference call. The 93%, the 6.5 times, the per-quarter average and the inventory change are our arithmetic, not company statements. We did not contact Aehr.

The Bottom Line

Aehr reported $33.0 million of revenue, up 200%, raised its fiscal 2027 outlook to $150 million and said its effective backlog reached $109.3 million, which by our arithmetic equals 93% of the revenue still needed to hit that outlook. Its quarter-end backlog is 6.5 times the level of a year earlier, and its operating cash flow was negative as receivables and inventories rose.